摘要
目的观察子宫动脉栓塞术治疗子宫肌瘤的效果。方法选取2019年4月至2020年3月本院收治的70例子宫肌瘤患者为研究对象,依据随机数字表法将其分为对照组(腹腔镜下子宫肌瘤剔除术)和观察组(子宫动脉栓塞术),各35例。比较两组的临床效果。结果两组的治疗总有效率无明显差异(P>0.05)。观察组的术后并发症总发生率低于对照组(P<0.05)。术后,两组的收缩期峰值流速(SPV)、舒张末期血流速度(EDV)均低于术前,搏动指数(PI)、阻力指数(RI)均高于术前,且观察组优于对照组(P<0.05)。术后,观察组的促卵泡激素(FSH)、雌二醇(E)、黄体生成素(LH)水平均高于对照组(P<0.05)。术后,两组的子宫体积及肌瘤体积均小于术前,且观察组小于对照组(P<0.05)。结论子宫动脉栓塞术治疗子宫肌瘤安全有效,有利于缩小患者的子宫体积、肌瘤体积,改善血流动力学和性激素水平。
Objective To observe the effect of uterine artery embolization in the treatment of uterine fibroids.Methods A total of 70 patients with uterine fibroids admitted in our hospital from April 2019 to March 2020 were selected as the research objects.According to the random number table method,the patients were divided into control group(laparoscopic myomectomy)and observation group(uterine artery embolization),with 35 cases in each group.The clinical effects of the two groups were compared.Results There was no significant difference in total effective rate of treatment between the two groups(P>0.05).The total incidence of postoperative complications in the observation group was lower than that in the control group(P<0.05).After operation,systolic peak velocity(SPV)and end diastolic velocity(EDV)of the two groups were lower than those before operation,pulsatility index(PI)and resistance index(RI)were higher than those before operation,and those of the observation group were better than the control group(P<0.05).After operation,the levels of follicle-stimulating hormone(FSH),estradiol(E2)and luteinizing hormone(LH)in the observation group were higher than those in the control group(P<0.05).After operation,the uterine volume and fibroid volume of the two groups were smaller than those before operation,and those of the observation group were smaller than the control group(P<0.05).Conclusion Uterine artery embolization in the treatment of uterine fibroids is safe and effective,which is beneficial to reduce the uterine volume and fibroid volume,improve the hemodynamics and sex hormone levels.
作者
耿冀洲
GENG Jizhou(Yan'an People's Hospital,Yan'an 716000,China)
出处
《临床医学研究与实践》
2022年第32期76-78,共3页
Clinical Research and Practice
